+Search query
-Structure paper
Title | PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis. |
---|---|
Journal, issue, pages | Cancer Discov, Page OF1-OFOF21, Year 2025 |
Publish date | Apr 28, 2025 |
![]() | Sheue-Fen Tzeng / Yi-Ru Yu / Jaeoh Park / Janusz von Renesse / Huey-Wen Hsiao / Chen-Hsuan Hsu / Josep Garnica / Jintian Chen / Lu-Ting Chiu / Jonas Santol / Tse-Yu Chen / Pei-Han Chung / Lana E Kandalaft / Patrick Starlinger / Rodney Cheng-En Hsieh / Ming-Chin Yu / Pei-Wen Hsiao / Santiago J Carmona / Hung-Kai Chen / Zhen Meng / Yun-Han Lin / Jingying Zhou / Chin-Hsien Tsai / Ping-Chih Ho / ![]() ![]() ![]() ![]() ![]() |
PubMed Abstract | Despite the success of cancer immunotherapies, like immune checkpoint inhibitors, many patients still fail to demonstrate significant responses because of metabolic constraints in tumors. PLT012 ...Despite the success of cancer immunotherapies, like immune checkpoint inhibitors, many patients still fail to demonstrate significant responses because of metabolic constraints in tumors. PLT012 rejuvenates antitumor immunity by targeting metabolic pathways to reprogram the immune landscape of liver cancer and liver metastasis, with potential to influence future HCC immunotherapy. |
![]() | ![]() ![]() ![]() |
Methods | EM (single particle) |
Resolution | 3.32 Å |
Structure data | ![]() EMDB-52203: Cryo-EM structure of CD36 protein complex with Fab |
Source |
|